JP2014507390A5 - - Google Patents

Download PDF

Info

Publication number
JP2014507390A5
JP2014507390A5 JP2013544781A JP2013544781A JP2014507390A5 JP 2014507390 A5 JP2014507390 A5 JP 2014507390A5 JP 2013544781 A JP2013544781 A JP 2013544781A JP 2013544781 A JP2013544781 A JP 2013544781A JP 2014507390 A5 JP2014507390 A5 JP 2014507390A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
spinal cord
stem cells
loss
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013544781A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014507390A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/065170 external-priority patent/WO2012083024A1/en
Publication of JP2014507390A publication Critical patent/JP2014507390A/ja
Publication of JP2014507390A5 publication Critical patent/JP2014507390A5/ja
Pending legal-status Critical Current

Links

JP2013544781A 2010-12-17 2011-12-15 胎盤幹細胞を用いる脊髄損傷及び外傷性脳損傷の治療 Pending JP2014507390A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201061424559P 2010-12-17 2010-12-17
US61/424,559 2010-12-17
PCT/US2011/065170 WO2012083024A1 (en) 2010-12-17 2011-12-15 Treatment of spinal cord injury and traumatic brain injury using placental stem cells

Publications (2)

Publication Number Publication Date
JP2014507390A JP2014507390A (ja) 2014-03-27
JP2014507390A5 true JP2014507390A5 (enExample) 2015-01-08

Family

ID=46234728

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013544781A Pending JP2014507390A (ja) 2010-12-17 2011-12-15 胎盤幹細胞を用いる脊髄損傷及び外傷性脳損傷の治療

Country Status (9)

Country Link
US (1) US20120156230A1 (enExample)
EP (1) EP2651451A4 (enExample)
JP (1) JP2014507390A (enExample)
KR (7) KR20200116546A (enExample)
CN (1) CN103501822A (enExample)
AU (1) AU2011343739A1 (enExample)
CA (1) CA2821818A1 (enExample)
MX (1) MX2013006595A (enExample)
WO (1) WO2012083024A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6204976B2 (ja) * 2012-05-16 2017-09-27 ベクトン・ディキンソン・アンド・カンパニーＢｅｃｔｏｎ， Ｄｉｃｋｉｎｓｏｎ Ａｎｄ Ｃｏｍｐａｎｙ 多能性幹細胞由来の細胞培養物からニューロンを単離するための細胞表面特性
JP2015521630A (ja) * 2012-06-26 2015-07-30 ラスティー プロパティー ホールディングス プロプライエタリー リミテッド 頭痛の頻度および／または重症度を下げるための組成物および方法
WO2014022427A1 (en) * 2012-08-02 2014-02-06 Bioaxone Biosciences Inc. Inhibition of rho and or rock and cell transplantation
EP2994147A4 (en) * 2013-05-10 2017-03-08 Cell-Innovations IP Pty Ltd Compositions and methods for the treatment of tinnitus
WO2015023901A1 (en) * 2013-08-15 2015-02-19 The Regents Of The University Of California Placenta-derived multipotent stem cells
DK3157548T3 (da) 2014-06-18 2021-09-06 Csl Behring Gmbh Terapi anvendelse af en faktor xii-inhibitor i en neurotraumatisk sygdom
US10493105B2 (en) * 2014-09-11 2019-12-03 Taiwan Mitochondrion Applied Technology Co., Ltd Isolated adipose-derived mesenchymal stem cells treated with angelica extract or butylidenephthalide, and wherein the cells have an increased mitochondrial membrane potential and a decreased level of IL-8, and methods for treating parkinson's disease
GB201518263D0 (en) * 2015-10-15 2015-12-02 Oxford Bioelectronics Ltd Method
EP3423070B1 (en) * 2016-03-03 2022-05-04 Henry Ford Health System 3-d collagen scaffold-generated exosomes and uses thereof
EA201991371A1 (ru) * 2016-12-05 2019-12-30 Селулэрити, Инк. Лечение лимфедемы и связанных состояний с использованием плацентарных адгезивных клеток
WO2018198012A1 (en) * 2017-04-24 2018-11-01 Pluristem Ltd. Methods and compositions for treating neurological disorders
US20180322956A1 (en) * 2017-05-05 2018-11-08 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Time Window-Based Platform for the Rapid Stratification of Blunt Trauma Patients into Distinct Outcome Cohorts
WO2018222723A1 (en) 2017-05-30 2018-12-06 Vertex Pharmaceuticals Incorporated C3 fusion protein and methods of making and using thereof
CN107227521B (zh) * 2017-08-09 2023-03-14 青岛金汇丰机械有限公司 一种五轴毛纺粗纱机
KR20190048894A (ko) 2017-10-31 2019-05-09 경상대학교산학협력단 Jnk 활성 억제제를 유효성분으로 포함하는 퇴행성 신경질환의 예방 또는 치료용 약학적 조성물
CN108413478A (zh) * 2018-02-11 2018-08-17 广东美的环境电器制造有限公司 一种控制方法、装置及计算机可读存储介质
KR102070403B1 (ko) 2019-09-06 2020-01-28 경상대학교 산학협력단 Jnk 활성 억제제를 유효성분으로 포함하는 외상성 뇌손상의 치료용 약학적 조성물
CN114561355B (zh) * 2022-01-23 2023-04-11 四川大学华西医院 一种脊髓瘢痕组织细胞急性快速分离方法
CN117274869B (zh) * 2023-09-25 2024-03-26 北方工业大学 一种基于形变场提取的细胞形变动态分类方法及系统

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7311905B2 (en) * 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
US20080152629A1 (en) * 2000-12-06 2008-06-26 James Edinger Placental stem cell populations
KR20180105266A (ko) * 2005-12-29 2018-09-27 안트로제네시스 코포레이션 태반 줄기 세포 집단
US20120269774A1 (en) * 2006-09-21 2012-10-25 Medistem Laboratories, Inc Allogeneic stem cell transplants in non-conditioned recipients
CN103356710A (zh) * 2007-02-12 2013-10-23 人类起源公司 利用胎盘干细胞治疗炎性疾病
US20090214484A1 (en) * 2008-02-22 2009-08-27 Nikolay Mironov Stem cell therapy for the treatment of central nervous system disorders
CA2734237C (en) * 2008-08-20 2019-07-02 Anthrogenesis Corporation Treatment of stroke using isolated placental cells
WO2010059828A1 (en) * 2008-11-19 2010-05-27 Anthrogenesis Corporation Amnion derived adherent cells

Similar Documents

Publication Publication Date Title
Ladenbauer et al. Brain stimulation during an afternoon nap boosts slow oscillatory activity and memory consolidation in older adults
Hugdahl Symmetry and asymmetry in the human brain
Small et al. Brain repair after stroke—a novel neurological model
Beghi et al. Idiopathic generalized epilepsies of adolescence
Prehn-Kristensen et al. Sleep restores daytime deficits in procedural memory in children with attention-deficit/hyperactivity disorder
Lüttjohann et al. Electrical stimulation of the epileptic focus in absence epileptic WAG/Rij rats: assessment of local and network excitability
Barber Evoked Potentials: Proceedings of an International Evoked Potentials Symposium Held in Nottingham, England
RU2678979C2 (ru) Средство для использования в гомеопатической технологии
Jambaqué et al. Cognitive disorders in pediatric epilepsy
Kumar et al. Efficacy of the combination of cognitive training and acoustic stimulation in eliciting lucid dreams during undisturbed sleep-A pilot study using polysomnography, dream reports and questionnaires
Gaudreault et al. Abnormal occipital event-related potentials in Parkinson's disease with concomitant REM sleep behavior disorder
Littlejohn et al. Fibromyalgia syndrome: which antidepressant drug should we choose
Reilly et al. Neuromodulation of cursing in American English: A combined tDCS and pupillometry study
Drago et al. Artistic creativity and DBS: a case report
Brukamp et al. Neuroenhancement-a controversial topic in contemporary medical ethics
El Shennawy et al. Electrophysiologic assessment of auditory function in children with autism and attentiondeficit and hyperactivity disorder
Lindsay Can hyper-synchrony in meditation lead to seizures? Similarities in meditative and epileptic brain states
Ashibokova et al. Interdisciplinary approach (neurologist and psychiatrist) in the treatment of chronic tension-type headaches
Rothstein The neural correlates of early identity and expression processing
MX2019013717A (es) Plasma de origen animal o fracciones del mismo para usarse en el tratamiento contra trastornos del deterioro cognitivo en humanos y animales de compañia.
Kislova et al. Characteristics of EEG in Subjects with High Level of Identification of Emotions in Speech.
Korenar Landau-Kleffner syndrome and swearing
RU2593886C1 (ru) Применение метилового эфира n-капроил-l-пролил-l-тирозина (дилепта) в качестве средства, обладающего психостимулирующей активностью
Heluani et al. 2.310 NEUROPSYCHOLOGICAL FINDINGS IN PATIENTS WITH PARKINSON'S DISEASE SUBMITTED TO UNILATERAL ABLATIVE PROCEDURES
Fusi et al. Divergent thinking: new insights about patients affected by Mild Cognitive Impairment